Literature DB >> 10834714

Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often.

M Rüdiger1, A von Baehr, R Haupt, R R Wauer, B Rüstow.   

Abstract

OBJECTIVE: Oxygen toxicity causes chronic bronchopulmonary dysplasia (BPD) in extremely preterm infants. Polyunsaturated fatty acids (PUFA) and plasmalogens are the two main substrates for lipid peroxidation in the pulmonary surfactant. In the present study, we tested whether low concentrations of both were associated with development of BPD and whether both were further reduced during mechanical ventilation with oxygen.
DESIGN: Prospective, noninterventional, descriptive study.
SETTING: Level III neonatal intensive care unit in a university hospital. PATIENTS: In 25 extremely low birth weight infants with respiratory distress syndrome, tracheal aspirates were collected immediately after birth and in the following 4 days. As control, tracheal and pharyngeal aspirates were collected from healthy infants immediately after birth. The amount of PUFA and dimethylacetals (DMA, representing plasmalogens) was determined gas-chromatographically.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The relative percentages of PUFA and DMA on all fatty acids in non-BPD infants (PUFA% 26+/-8.9, DMA% 3.5+/-1.2) were higher compared with infants who developed BPD (PUFA% 14.5+/-3.8, DMA% 1.8+/-0.9). In term healthy infants, DMA% and PUFA% were in the same range as in the BPD group. The higher levels found for non-BPD infants decreased after day 1 to values equal to the BPD group and remained low.
CONCLUSIONS: The results suggest that initially higher levels of PUFA and plasmalogens in the tracheal effluent are associated with a reduced risk of developing BPD and are reduced during the first day of ventilation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10834714     DOI: 10.1097/00003246-200005000-00052

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  15 in total

Review 1.  The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.

Authors:  Carlo Dani; Chiara Poggi
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

2.  Serum Metabolome Is Associated With the Nasopharyngeal Microbiota and Disease Severity Among Infants With Bronchiolitis.

Authors:  Christopher J Stewart; Jonathan M Mansbach; Nadim J Ajami; Joseph F Petrosino; Zhaozhong Zhu; Liming Liang; Carlos A Camargo; Kohei Hasegawa
Journal:  J Infect Dis       Date:  2019-05-24       Impact factor: 5.226

3.  Plasma Lipid Profiling Identifies Phosphatidylcholine 34:3 and Triglyceride 52:3 as Potential Markers Associated with Disease Severity and Oxidative Status in Chronic Obstructive Pulmonary Disease.

Authors:  Amel Ben Anes; Hela Ben Nasr; Zouhair Tabka; Oussama Tabka; Monia Zaouali; Karim Chahed
Journal:  Lung       Date:  2022-07-11       Impact factor: 3.777

4.  Respiratory viruses are associated with serum metabolome among infants hospitalized for bronchiolitis: A multicenter study.

Authors:  Michimasa Fujiogi; Carlos A Camargo; Yoshihiko Raita; Yury A Bochkov; James E Gern; Jonathan M Mansbach; Pedro A Piedra; Kohei Hasegawa
Journal:  Pediatr Allergy Immunol       Date:  2020-06-10       Impact factor: 6.377

Review 5.  Biomarkers, Early Diagnosis, and Clinical Predictors of Bronchopulmonary Dysplasia.

Authors:  Charitharth Vivek Lal; Namasivayam Ambalavanan
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

6.  Developmental changes in polyunsaturated fetal plasma phospholipids and feto-maternal plasma phospholipid ratios and their association with bronchopulmonary dysplasia.

Authors:  Wolfgang Bernhard; Marco Raith; Vera Koch; Christoph Maas; Harald Abele; Christian F Poets; Axel R Franz
Journal:  Eur J Nutr       Date:  2015-09-12       Impact factor: 5.614

7.  A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton.

Authors:  Nancy Braverman; Rui Zhang; Li Chen; Graeme Nimmo; Sarah Scheper; Tammy Tran; Rupsa Chaudhury; Ann Moser; Steven Steinberg
Journal:  Mol Genet Metab       Date:  2009-12-11       Impact factor: 4.797

8.  Low-concentration ozone reacts with plasmalogen glycerophosphoethanolamine lipids in lung surfactant.

Authors:  Kelly M Wynalda; Robert C Murphy
Journal:  Chem Res Toxicol       Date:  2010-01       Impact factor: 3.739

9.  Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.

Authors:  Ga Won Jeon; Minkyung Oh; Jong Beom Sin
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

Review 10.  Antioxidant strategies and respiratory disease of the preterm newborn: an update.

Authors:  Chiara Poggi; Carlo Dani
Journal:  Oxid Med Cell Longev       Date:  2014-04-07       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.